Estimate the financial risk in your billing portfolio

See how denial rates, rework volume, and A/R trends may be contributing to financial risk across your client portfolio.

Where is financial risk building?

Answer six quick questions to estimate denial-related revenue risk, operational rework cost, and per-client impact.

1-23-45-67+
Under 30 days30–40 days41–55 days56+ days

* Estimates based on HFMA's 5% denial rate benchmark, the American Medical Association's $25 per-denied-claim rework cost estimate, and a 2-touch denied-claim resolution assumption. Results vary by payer mix, specialty, claim complexity, and staffing. This calculator estimates financial risk, not recoverable revenue or guaranteed collections improvement.

Your denied claims and rework cost are building financial risk

$XX/month$XX/year

See how that exposure breaks down ↓

What your denial rate is putting at risk

Your denial rate is XX% points above the 5% benchmark, representing XX excess denied claims per month and an estimated $XX/month in revenue exposure. As denied claims accumulate above benchmark range, financial exposure compounds across the portfolio.

What rework is costing your team

At XX touches per denied claim, your team is absorbing approximately $XX/month in operational rework exposure across XX denied claims each month. Additional touches increase staffing burden and compress margin across the portfolio.

Your average exposure per client

Across XX clients, exposure averages $XX per practice each month.

Make revenue risk visible before it impacts cash flow

Financial exposure rarely comes from a single denied claim. It builds across denial trends, rework loops, and aging A/R. See how better visibility helps billing companies identify risk earlier across the portfolio.

Take a self-guided tour

See how billing companies monitor denial trends, A/R aging, and operational exposure across their client portfolio.

Schedule your personalized demo

See how billing companies gain earlier visibility into denial exposure, rework trends, and portfolio-level financial risk.

Talk through your exposure signals

Get tailored guidance on identifying denial-related exposure, operational rework burden, and A/R risk across your portfolio.

Frequently asked questions

Frequently asked questions

Financial exposure in a medical billing company is the combined impact of revenue at risk from denied claims and the operational cost of resolving those claims. It includes claim rework, payer follow-up, and aging accounts receivable (A/R) that may delay or reduce collections across a client portfolio.
A healthy claim denial rate for a medical billing company is generally 5% or lower, based on the industry benchmark commonly referenced by HFMA. Denial rates above 5% may indicate increased revenue cycle risk, higher claim rework costs, growing accounts receivable (A/R), and greater financial exposure across the portfolio.
Denied claims create operational costs because they require staff time to review, correct, resubmit, and track claims through resolution. Every additional touch adds labor, slows workflows, and increases rework across the portfolio. As denial volume rises, billing companies often spend more time resolving claims and less time on higher-value work.
Days in accounts receivable (A/R) measures the average time it takes for claims to be paid after submission. Rising days in A/R may signal delayed collections, unresolved denied claims, payer-related friction, or growing revenue cycle risk. Medical billing companies often monitor A/R aging as a key indicator of portfolio health and financial performance.
Billing companies measure denial-related revenue risk by tracking claim denial rates, denied-claim volume, average collected revenue per claim, claim rework activity, and accounts receivable (A/R) aging trends. Looking at these metrics together helps identify financial exposure and operational risk across a client portfolio.